Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects: a pilot study

J Biol Regul Homeost Agents. 2021 May-Jun;35(3):1151-1154. doi: 10.23812/21-138-L.

Authors

G Ciprandi¹, I La Mantia², F P Brunese³, Al Varricchio⁴, At Varricchio⁵

Affiliations

¹ Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy.
² ENT Department, University of Catania, Catania, Italy.
³ Primary Care Paediatrics, ASL Caserta, Italy.
⁴ ENT Department, Ospedale Santobono, Naples, Italy.
⁵ UOSD Video-Endoscopia delle VAS, P.O. San Gennaro - ASL Napoli 1-centro, Naples, Italy.

PMID: 34229425
DOI: 10.23812/21-138-L

No abstract available

Keywords: aerosolization; hyaluronic acid; hypertonic saline; symptomless COVID-19; topical antibiotics; viral shedding; xylitol.

Publication types

Letter

MeSH terms

COVID-19*
Humans
Pilot Projects
SARS-CoV-2
Saline Solution, Hypertonic
Virus Shedding
Xylitol*

Substances

Saline Solution, Hypertonic
Xylitol